─ 278 ─ Cardiovascular diseases (CVDs) account for > 17 million deaths globally each year (30% of all deaths), and the number is expected to grow to 23.6 million by 2030. Among CVDs, coronary artery disease (CAD) is the most prevalent.
cause this technique is invasive, IVUS and optical coherence tomography (OCT) usually take place during percutaneous coronary intervention (PCI). To evaluate coronary atherosclerosis for primary or secondary prevention, a less invasive method of in vivo imaging is desirable. Coronary computed tomography (CT) can identify plaque characteristics based on findings of CT value, calcification, and vessel remodeling. Motoyama and colleagues showed that patients with positive vessel remodeling and low-attenuation plaques revealed by CT angiography are at higher risk of future coronary events than patients whose lesions lack these characteristics. 7) However, because CT requires both ionizing radiation exposure and iodide contrast medium, it is considered to be unsuitable for coronary artery screening in the general population. Coronary positron emission tomography (PET) is also a useful technique, 8) but it is only available in a limited number of institutions, and its methodology and clinical significance (including prognostic impact) have not been completely determined. Consequently, there is still a need for a less invasive method of CVD detection prior to clinical events.
9)
Magnetic resonance imaging (MRI) is a promising technology for clinical application because multi-contrast images obtained by multiple sequences can differentiate plaque components based on their biophysical and biochemical parameters. Moreover, MRI does not utilize ionizing radiation, even in the absence of contrast medium, and can be repeated sequentially over time.
In this review, we will discuss the potential of MRI for screening and managing coronary atherosclerosis.
I. Magnetic resonance imaging for atherosclerotic plaques
Atherosclerotic plaque characterization by MRI is based on the signal intensity and morphologic appearance of plaques in multiple contrast weightings. MRI detects electromagnetic signals at radio wavelengths emitted by protons in a strong magnetic field. In clinical practice, MRI mainly visualizes signals from 
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Identification of high-risk coronary plaques is important for management of patients with coronary artery disease (CAD) to prevent future cardiovascular events including death, heart failure, and fatal myocardial infarction. Many studies have described the characteristics of coronary plaques and their clinical outcomes, based on invasive intravascular coronary imaging. Recent technical advancements in multi-slice computed tomography, positron emission tomography, and magnetic resonance imaging (MRI) provide methods for less invasive detection of high-risk coronary atherosclerosis. Our research has focused on understanding the development of coronary atherosclerosis and its clinical outcomes using non-contrast T1-weighted MRI (T1WI), which is non-invasive and does not require the use of ionizing radiation or iodide contrast medium. We have shown that coronary high-intensity plaques (HIPs) detected by non-contrast T1WI are associated with high clinical risk, and therefore might have potential applications in monitoring pharmacological interventions and advancing preemptive medicine in CAD patients. However, the histopathological and molecular mechanisms underlying coronary HIPs remain undetermined. Future studies using a combination of multi-modality images and molecular analysis may facilitate an improved understanding of the molecular dynamics of coronary HIPs.
─ 279 ─ ischemic events. 15, 16) ─ 280 ─ plaques.
To clarify the clinical signifi cance of coronary HIPs detected by non-contrast T1WI as biomarkers, we sought to examine 1) whether coronary MRI can predict future cardiac events and identify the periprocedural risk during percutaneous coronary intervention (PCI), and 2) whether coronary MRI can evaluate plaque characteristics or monitor their changes.
III. Clinical significance of coronary HIPs detected by non-contrast T1WI as biomarkers
To investigate the prognostic impact of coronary HIPs, we examined 568 patients with suspected or known coronary artery disease (CAD), 25) who were initially screened by CT angiography (CTA) and subsequently underwent 1.5-T MRI examinations to evaluate coronary plaques. During a median of 55 months of follow-up, 55 coronary events were observed. To quantitate plaques, the plaque to myocardium signal intensity ratio (PMR)
was calculated in each case of coronary atherosclerosis (Fig. 3 ).
PMR was higher in patients with coronary events than in those without coronary events (with: 1.49 ; without: 0.94 ; P < 0.001).
Based on receiver operating characteristic (ROC) curve analysis, the optimal PMR cutoff value for predicting cardiac events was 
II. Clinical application of non-contrast T1-weighted imaging (T1WI) in coronary atherosclerosis
In contrast to carotid artery MRI, development of MRI for coronary arteries poses several challenges, largely because coronary plaques are small targets, and breathing and motion artifacts impair MRI acquisition. Fayad and colleagues were the fi rst to demonstrate the feasibility of coronary plaque imaging in humans in vivo 20) . In addition, Botnar, Stuber, and colleagues reported high-resolution coronary plaque imaging during free breathing using a combination of a real-time navigator for respiratory gating and real-time slice-position correction. (Fig. 4) . The results of that study indicate that non-contrast T1W1 has the potential to detect high-risk coronary plaques and predict future coronary events.
To investigate the clinical applications of non-contrast T1WI
during PCI, we also examined the relationship between MRI fi ndings of coronary HIPs and periprocedural myocardial injuries (pMI), defi ned as an increase in serum cardiac troponin T (cTnT) levels more than 5 times the upper limit of normal (0.07 ng/ml) 24 h after PCI, following elective PCI in patients with stable CAD. ─ 282 ─ by the same group revealed that high-intensity signals on T1WI
at the culprit lesion in both stable CAD and ACS patients were associated with clinical presentation, and coronary HIPs were more frequent in ACS patients (ACS patients: 72% ; stable patients: 45%). 35) However, they did not mention the OCT fi ndings, especially in stable CAD patients, because of the limited number of patients enrolled in their study (42 of 100 patients).
35) Therefore, for our comparison of the findings of coronary MR and OCT, we focused on patients with stable CAD eligible for PCI.
36)
Our study showed that the prevalence of intracoronary thrombi detected on OCT was comparable between the coronary HIPs group and the non-HIPs group. In addition, we also investigated the histopathological fi ndings of coronary HIPs in stable CAD patients from samples in which coronary embolus from the culprit lesion occurred during PCI. Histological findings of coronary emboli revealed a large amount of necrotic core with overpitavastatin to achieve an LDL-cholesterol (LDL-C) level < 80 
32)
IV. What are the coronary high-intensity plaques detected by T1WI: plaque components or intravascular thrombi?
As mentioned above, non-contrast T1WI for coronary athero- in patients with both stable and unstable angina pectoris. 34) They demonstrated that the prevalence of intraluminal thrombi confi rmed by OCT was higher in the coronary HIPs group than in the non-HIPs group, whereas the prevalences of lipid-rich plaques, thin-cap fi broatheromas, plaque rupture, and calcifi cation on OCT were comparable. 34) Moreover, a more recent study Further studies are needed to screen functional target molecules to improve visualization of atherosclerosis.
VI. Unresolved issues of coronary MRI and future perspectives
MRPAGE imaging of coronary atherosclerosis is a promising method for detection of high-risk plaques. However, several problems must be overcome in order to apply non-contrast T1WI
as a clinical diagnostic tool.
First, evaluation of coronary plaques by T1WI requires relatively long scan times (15-20 minutes per patient to visualize coronary plaques in the whole heart. 25, 35) In most institutes where MRI is available, the MRI facility is also used for neurovascular or orthopedic patients ; consequently, few scan time slots are available to perform additional examinations of CVD patients. In contemporary clinical practice, in order to balance scan time and clinical signifi cance, most institutes tend to choose other modalities to evaluate coronary plaques (e.g., coronary CT or invasive coronary angiography). In addition, MRI is both high-tech and high-cost. 9) Rising health-care costs could lead to a fi scal crisis lying platelet-and fi brin-rich thrombi (Fig. 5) , 37) suggesting that coronary HIPs might consist, at least in part, of a large amount of necrotic core with IPH. Further studies will be needed to clarify this important issue.
V. MRI contrast agents to detect high-risk coronary plaques
For coronary wall images, non-targeting gadolinium-based contrast agents can enhance coronary atherosclerosis because of the presence of infl ammation and absence of endothelium, 38) and the area of enhancement is associated with the severity of atherosclerosis as detected on coronary CT and quantitative CAG.
39, 40)
For a better understanding of the functional and molecular mechanisms of processing atherosclerosis, targeted contrast agents for atherosclerosis will be needed for MRI, as is the case for non-invasive cancer assessments. because health care costs already account for a major fraction of gross domestic product (GDP) in Japan. 
VII. Conclusions
Recent findings from our laboratory and others suggest that coronary MRI, especially in T1WI, would have clinical applications as potential biomarkers to identify high-risk patients susceptible to future coronary events, and could be used to advance preemptive medicine by enabling early intervention (Fig. 6 ).
However, our understanding of the mechanisms of coronary plaque components (i.e., histology and molecular constituents) detected by T1WI remains incomplete. The development of new molecular imaging probes with specific biological functions could add new dimensions to plaque imaging. Further studies are needed to clarify the histopathology and molecular mechanisms of coronary HIPs.
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